Quantitative Influence of Antibody and Complement Coating of Red Cells on Monocyte-mediated Cell Lysis
Overview
Authors
Affiliations
Monocyte-mediated lysis in vitro of human red cells coated with measured amounts of immunoglobulin G (IgG) or complement were studied. 1,000-1,500 molecules of IgG anti-D are necessary to effect measurable lysis, and lysis increases linearly with increasing levels of antibody sensitization. 100 microgram/ml of IgG1 abolished lysis even at maximal levels of anti-D sensitization (15,000 molecules/cell). Two isoimmune IgG anti-A or anti-B antisera were 5 to 10-fold less efficient in promoting phagocytosis or lysis per molecule of IgG bound; however, because of the greater antigen density of A or B, more than 100,000 molecules IgG/cell could be bound, producing equivalent lysis to anti-D-coated cells. Although inhibition by IgG1 was similar at equivalent levels of sensitization with anti-A, anti-B, or anti-D at high levels of coating with anti-A or anti-B (not attainable with anti-D), lysis was not inhibited by IgG1. Cells coated with human complement components alone were not lysed by monocytes; however, complement coating augmented IgG-mediated lysis and reduced the quantity of anti-D necessary to produce lysis to less than 1,000 molecules/cell. After thorough degradation of C3b by serum to C3d, complement augmentation persisted.
Boussaid S, Tbini H, Rekik S, Khaled S, Rahmouni S, Zouaoui K Mediterr J Rheumatol. 2024; 35(3):448-458.
PMID: 39463880 PMC: 11500116. DOI: 10.31138/mjr.090723.pof.
Yin W, Yuan J, Zhang Z, Mei C, Xu W, Tang Y Sci Rep. 2021; 11(1):2505.
PMID: 33510312 PMC: 7844045. DOI: 10.1038/s41598-021-82100-y.
Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered.
Gong S, Ruprecht R Front Immunol. 2020; 11:1943.
PMID: 32849652 PMC: 7432194. DOI: 10.3389/fimmu.2020.01943.
Pandey P, Anani W, Pugh T, Gottschall J, Denomme G J Transl Med. 2020; 18(1):216.
PMID: 32466782 PMC: 7257204. DOI: 10.1186/s12967-020-02378-w.
Farmer J, Ong M, Barmettler S, Yonker L, Fuleihan R, Sullivan K Front Immunol. 2018; 8:1740.
PMID: 29375540 PMC: 5767273. DOI: 10.3389/fimmu.2017.01740.